Projecting the impact of Covid-19 variants and vaccination strategies in disease transmission using a multilayer network model in Costa Rica
- PMID: 35145180
- PMCID: PMC8831570
- DOI: 10.1038/s41598-022-06236-1
Projecting the impact of Covid-19 variants and vaccination strategies in disease transmission using a multilayer network model in Costa Rica
Abstract
For countries starting to receive steady supplies of vaccines against SARS-CoV-2, the course of Covid-19 for the following months will be determined by the emergence of new variants and successful roll-out of vaccination campaigns. To anticipate this scenario, we used a multilayer network model developed to forecast the transmission dynamics of Covid-19 in Costa Rica, and to estimate the impact of the introduction of the Delta variant in the country, under two plausible vaccination scenarios, one sustaining Costa Rica's July 2021 vaccination pace of 30,000 doses per day and with high acceptance from the population and another with declining vaccination pace to 13,000 doses per day and with lower acceptance. Results suggest that the introduction and gradual dominance of the Delta variant would increase Covid-19 hospitalizations and ICU admissions by [Formula: see text] and [Formula: see text], respectively, from August 2021 to December 2021, depending on vaccine administration and acceptance. In the presence of the Delta variant, new Covid-19 hospitalizations and ICU admissions are estimated to increase around [Formula: see text] and [Formula: see text], respectively, in the same period if the vaccination pace drops. Our results can help decision-makers better prepare for the Covid-19 pandemic in the months to come.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.JMIR Public Health Surveill. 2022 May 20;8(5):e35054. doi: 10.2196/35054. JMIR Public Health Surveill. 2022. PMID: 35483079 Free PMC article.
-
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28. Lancet. 2021. PMID: 34717829 Free PMC article.
-
SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.Infect Genet Evol. 2021 Aug;92:104872. doi: 10.1016/j.meegid.2021.104872. Epub 2021 Apr 24. Infect Genet Evol. 2021. PMID: 33905892 Free PMC article.
-
Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa Rica.BMC Infect Dis. 2022 Oct 2;22(1):767. doi: 10.1186/s12879-022-07740-5. BMC Infect Dis. 2022. PMID: 36184587 Free PMC article.
-
Impact of the Delta variant on vaccine efficacy and response strategies.Expert Rev Vaccines. 2021 Oct;20(10):1201-1209. doi: 10.1080/14760584.2021.1976153. Epub 2021 Sep 9. Expert Rev Vaccines. 2021. PMID: 34488546 Free PMC article. Review.
Cited by
-
Prediction of SARS-CoV-2 infection cases based on the meta-SEIRS model.Epidemiol Infect. 2024 Nov 18;152:e144. doi: 10.1017/S0950268824001274. Epidemiol Infect. 2024. PMID: 39552127 Free PMC article.
-
Mathematical and statistical models for the control of mosquito-borne diseases: the experience of Costa Rica.Rev Panam Salud Publica. 2022 Aug 30;46:e113. doi: 10.26633/RPSP.2022.113. eCollection 2022. Rev Panam Salud Publica. 2022. PMID: 36060201 Free PMC article.
-
Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.Syst Rev. 2024 Jan 16;13(1):30. doi: 10.1186/s13643-023-02411-1. Syst Rev. 2024. PMID: 38229123 Free PMC article.
-
A COVID-19 model incorporating variants, vaccination, waning immunity, and population behavior.Sci Rep. 2022 Nov 27;12(1):20377. doi: 10.1038/s41598-022-24967-z. Sci Rep. 2022. PMID: 36437375 Free PMC article.
References
-
- Basta, N. & Moodie, E. COVID-19 vaccine development and approvals tracker. https://covid19.trackvaccines.org/vaccines/approved/#vaccine-list (2021).
-
- WHO. COVID-19 vaccine tracker and landscape. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand... (2021).
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous